{"id":"W4387569385","doi":"10.1136/ard-2023-224762","title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":933,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Versus Arthritis; Pfizer; Eli Lilly and Company; European League Against Rheumatism; Amgen","keywords":"Medicine; Belimumab; Azathioprine; Rituximab; Hydroxychloroquine; Lupus nephritis; Nintedanib; Efalizumab; Systemic lupus erythematosus; Abatacept; Prednisone; Maintenance therapy; Internal medicine; Intensive care medicine; Immunology; Disease; Infliximab; Idiopathic pulmonary fibrosis; B-cell activating factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07888403940579979,"score_gpt":0.3650390042871462,"score_spread":0.2861549648813464,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}